| ACD440 Gel in Peripheral Neuropathic Pain (NCT05416931) | AlzeCure Pharma | 2022-06-20 |
| To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia (NCT05890053) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-17 |
| A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain (NCT05219812) | Bayer | 2022-02-16 |
| Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning (NCT06234917) | Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy) | 2021-01-04 |
| Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain (NCT04431778) | University Hospital, Clermont-Ferrand | 2020-11-01 |
| A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (NCT04494815) | Shanghai SIMR Biotechnology Co., Ltd. | 2020-09-18 |
| Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets (NCT04171453) | Viatris Korea | 2020-02-03 |
| Burst Spinal Cord Stimulation for Neuropathic Pain. (NCT03733886) | Oslo University Hospital | 2019-09-09 |
| Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers (NCT03191136) | Yuhan Corporation | 2017-05-10 |
| Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain (NCT02985216) | Yuhan Corporation | 2017-02-07 |
| Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain (NCT03009500) | University Health Network, Toronto | 2017-01-01 |
| BlueWind Reprieve System for the Treatment of PNP (NCT02209896) | BlueWind Medical | 2014-12-01 |
| Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. (NCT02100046) | University Hospital, Clermont-Ferrand | 2014-03-01 |
| Observation of the Use of QUTENZA™ in Standard Clinical Practice (NCT01737294) | Astellas Pharma Europe Ltd. | 2012-02-01 |
| Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage (NCT01293851) | National Institute of Nursing Research (NINR) | 2010-12-22 |
| Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers (NCT01240148) | AstraZeneca | 2010-12-01 |